共 56 条
[1]
Rath H.C., Herfarth H.H., Ikeda J.S., Et al., Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats, J Clin Invest, 98, pp. 945-953, (1996)
[2]
Sellon R.K., Tonkonogy S., Schultz M., Et al., Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect Immun, 66, pp. 5224-5231, (1998)
[3]
Duchmann R., Kaiser I., Hermann E., Et al., Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD), Clin Exp Immunol, 102, pp. 448-455, (1995)
[4]
Swidsinski A., Ladhoff A., Pernthaler A., Et al., Mucosal flora in inflammatory bowel disease, Gastroenterology, 122, pp. 44-54, (2002)
[5]
Kleessen B., Kroesen A.J., Buhr H.J., Blaut M., Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls, Scand J Gastroenterol, 37, pp. 1034-1041, (2002)
[6]
Chapman R.W., Selby W.S., Jewell D.P., Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis, Gut, 27, pp. 1210-1212, (1986)
[7]
Mantzaris G.J., Hatzis A., Kontogiannis P., Triadaphyllou G., Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis, Am J Gastroenterol, 89, pp. 43-46, (1994)
[8]
Mantzaris G.J., Petraki K., Archavlis E., Et al., A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis, Scand J Gastroenterol, 36, pp. 971-974, (2001)
[9]
Lobo A.J., Burke D.A., Sobala G.M., Axon A.T., Oral tobramycin in ulcerative colitis: Effect on maintenance of remission, Aliment Pharmacol Ther, 7, pp. 155-158, (1993)
[10]
Guslandi M., Petrone M.C., Testoni P.A., Rifaximin for active ulcerative colitis, Inflamm Bowel Dis, 12, (2006)